Skip to main content
Back
Watch Compare

Concord Medical Services Holdings Ltd

Data quality: 100%
CCM
NYSE Services Health Services
$3.67
$0.00 (0.00%)
Mkt Cap: 15.93 M
Price
$3.67
Mkt Cap
15.93 M
Day Range
$3.67 — $3.67
52-Week Range
$3.18 — $10.77
Volume
6
Open $3.67
50D / 200D Avg
$3.82
3.84% below
50D / 200D Avg
$4.80
23.62% below

Quick Summary

Key Takeaways

Revenue grew 11.38% annually over 5 years — strong growth
Negative free cash flow of -75.15 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 41.88%
Capital intensive — 39.27% of revenue goes to capex

Growth

Revenue Growth (5Y)
11.38%
Above sector avg (3.99%)
Revenue (1Y)-30.50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-8.58%
Net Margin-80.28%
Op. Margin-138.60%

Safety

Debt / Equity
N/A
Current Ratio0.46
Interest Coverage-2.75

Valuation

PE (TTM)
-0.38
Above sector avg (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Services sector median (502 peers)
Metric Stock Sector Median
P/E -0.4 -1.2
P/B — 1.4
ROE % — -16.0
Net Margin % -80.3 -19.4
Rev Growth 5Y % 11.4 4.0
D/E — 0.4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -30.50% Revenue Growth (3Y) -12.33%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 11.38% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 52.60 M Net Income (TTM) -42.23 M
ROE N/A ROA -4.76%
Gross Margin -20.62% Operating Margin -138.60%
Net Margin -80.28% Free Cash Flow (TTM) -75.15 M
ROIC -8.58% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.46
Interest Coverage -2.75 Asset Turnover 0.06
Working Capital -156.37 M Tangible Book Value -430.83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.38 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0.30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -471.61%
Market Cap 15.93 M Enterprise Value 444.35 M
Per Share
EPS (Diluted TTM) -0.32 Revenue / Share 12.12
FCF / Share -17.31 OCF / Share -12.55
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 39.27% FCF Conversion 177.96%
SBC-Adj. FCF N/A Growth Momentum -41.88

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 52.60 M 75.69 M 68.45 M 76.21 M 34.18 M
Net Income -42.23 M -41.93 M -70.99 M -42.59 M -47.51 M
EPS (Diluted) -0.32 -0.32 -0.54 — —
Gross Profit -10.85 M -10.79 M -22.10 M -8.93 M 2.01 M
Operating Income -72.91 M -65.21 M -76.13 M -71.92 M -48.43 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 26.47 M 23.33 M 17.45 M 11.58 M 12.47 M
Income Tax -2.40 M -3.46 M -10.28 M -1.03 M -5.77 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 921.51 M 852.68 M 870.63 M 977.62 M 817.55 M
Total Liabilities 699.88 M 606.62 M 578.39 M 547.07 M 449.61 M
Shareholders' Equity -312.41 M -298.87 M -270.25 M -215.00 M -101.60 M
Total Debt 458.04 M 325.87 M 382.77 M 363.29 M 305.37 M
Cash & Equivalents 29.62 M 8.19 M 22.95 M 24.70 M 51.23 M
Current Assets 134.80 M 86.93 M 110.16 M 91.72 M 103.60 M
Current Liabilities 291.17 M 274.85 M 162.57 M 126.25 M 78.49 M